These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 20359301)

  • 1. Antibody validation.
    Bordeaux J; Welsh A; Agarwal S; Killiam E; Baquero M; Hanna J; Anagnostou V; Rimm D
    Biotechniques; 2010 Mar; 48(3):197-209. PubMed ID: 20359301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines on antibody use in physiology research.
    Brooks HL; de Castro Brás LE; Brunt KR; Sylvester MA; Parvatiyar MS; Sirish P; Bansal SS; Sule R; Eadie AL; Knepper MA; Fenton RA; Lindsey ML; DeLeon-Pennell KY; Gomes AV
    Am J Physiol Renal Physiol; 2024 Mar; 326(3):F511-F533. PubMed ID: 38234298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten Basic Rules of Antibody Validation.
    Weller MG
    Anal Chem Insights; 2018; 13():1177390118757462. PubMed ID: 29467569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility: Standardize antibodies used in research.
    Bradbury A; Plückthun A
    Nature; 2015 Feb; 518(7537):27-9. PubMed ID: 25652980
    [No Abstract]   [Full Text] [Related]  

  • 5. A proposal for validation of antibodies.
    Uhlen M; Bandrowski A; Carr S; Edwards A; Ellenberg J; Lundberg E; Rimm DL; Rodriguez H; Hiltke T; Snyder M; Yamamoto T
    Nat Methods; 2016 Oct; 13(10):823-7. PubMed ID: 27595404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility crisis: Blame it on the antibodies.
    Baker M
    Nature; 2015 May; 521(7552):274-6. PubMed ID: 25993940
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody validation by Western blotting.
    Signore M; Reeder KA
    Methods Mol Biol; 2012; 823():139-55. PubMed ID: 22081344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development: Raise standards for preclinical cancer research.
    Begley CG; Ellis LM
    Nature; 2012 Mar; 483(7391):531-3. PubMed ID: 22460880
    [No Abstract]   [Full Text] [Related]  

  • 9. An assessment of histone-modification antibody quality.
    Egelhofer TA; Minoda A; Klugman S; Lee K; Kolasinska-Zwierz P; Alekseyenko AA; Cheung MS; Day DS; Gadel S; Gorchakov AA; Gu T; Kharchenko PV; Kuan S; Latorre I; Linder-Basso D; Luu Y; Ngo Q; Perry M; Rechtsteiner A; Riddle NC; Schwartz YB; Shanower GA; Vielle A; Ahringer J; Elgin SC; Kuroda MI; Pirrotta V; Ren B; Strome S; Park PJ; Karpen GH; Hawkins RD; Lieb JD
    Nat Struct Mol Biol; 2011 Jan; 18(1):91-3. PubMed ID: 21131980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to avoid pitfalls in antibody use.
    Pauly D; Hanack K
    F1000Res; 2015; 4():691. PubMed ID: 26834988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research.
    Prassas I; Diamandis EP
    Clin Chem Lab Med; 2014 Jun; 52(6):765-6. PubMed ID: 24497227
    [No Abstract]   [Full Text] [Related]  

  • 12. On the reproducibility of science: unique identification of research resources in the biomedical literature.
    Vasilevsky NA; Brush MH; Paddock H; Ponting L; Tripathy SJ; Larocca GM; Haendel MA
    PeerJ; 2013; 1():e148. PubMed ID: 24032093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European antibody network's practical guide to finding and validating suitable antibodies for research.
    Roncador G; Engel P; Maestre L; Anderson AP; Cordell JL; Cragg MS; Šerbec VČ; Jones M; Lisnic VJ; Kremer L; Li D; Koch-Nolte F; Pascual N; Rodríguez-Barbosa JI; Torensma R; Turley H; Pulford K; Banham AH
    MAbs; 2016; 8(1):27-36. PubMed ID: 26418356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent immunohistochemistry: pitfalls and troubleshooting.
    Ward JM; Rehg JE
    Vet Pathol; 2014 Jan; 51(1):88-101. PubMed ID: 24078006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins.
    Slaastad H; Wu W; Goullart L; Kanderova V; Tjønnfjord G; Stuchly J; Kalina T; Holm A; Lund-Johansen F
    Proteomics; 2011 Dec; 11(23):4578-82. PubMed ID: 21956872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies: The solution is validation.
    Polakiewicz RD
    Nature; 2015 Feb; 518(7540):483. PubMed ID: 25719656
    [No Abstract]   [Full Text] [Related]  

  • 17. Policy: NIH plans to enhance reproducibility.
    Collins FS; Tabak LA
    Nature; 2014 Jan; 505(7485):612-3. PubMed ID: 24482835
    [No Abstract]   [Full Text] [Related]  

  • 18. Working towards a consensus for antibody validation.
    Reiss PD; Min D; Leung MY
    F1000Res; 2014; 3():266. PubMed ID: 25580232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematoxylin and eosin staining of tissue and cell sections.
    Fischer AH; Jacobson KA; Rose J; Zeller R
    CSH Protoc; 2008 May; 2008():pdb.prot4986. PubMed ID: 21356829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR and KRAS in colorectal cancer.
    Markman B; Javier Ramos F; Capdevila J; Tabernero J
    Adv Clin Chem; 2010; 51():71-119. PubMed ID: 20857619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.